December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer
Sep 19, 2024, 12:03

Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer

Dana-Farber’s Breast Oncology Center shared on X:

“Hot off the Press!

Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer with or without Brain Metastases practice changing results from a phase 3b/4 trial.”

Breast Cancer

Source: Dana-Farber’s Breast Oncology Center/X